Enhanced in vitro activity of WR99210 in combination with dapsone against Mycobacterium avium complex.

WR99210, a dihydrofolate reductase inhibitor, has promising in vitro activity against Mycobacterium avium complex (MAC). The in vitro activities of WR99210 alone and in combination with a fixed concentration of dapsone (0.5 microgram/ml) were evaluated against 35 clinical MAC isolates by a broth dil...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Shah, L M, DeStefano, M S, Cynamon, M H
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1996
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163591/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8913480/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.11.2644
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!